New study: Treatment of chronic patellar tendinopathy with autologous bone marrow stem cells: a 5-year-followup.
According to results, inoculation of BM-MNCs could be considered as a potential therapy for those patients with chronic patellar tendinopathy refractory to nonoperative treatments.
Read Full Article: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246763/
This 5-year study is promising and more are needed to determine effectiveness of regenerative treatment options and protocols in this rapidly advancing field.
For more of the latest research and clinical experience, attend The Orthobiologic Institute (TOBI) 4th Annual PRP & Regenerative Medicine Symposium, June 7-8, 2013 in Los Angeles. Details and registration at www.prpseminar.com.